| Product Information |
|
| Registration Number |
BR-1464
|
| Generic Name |
Trastuzumab deruxtecan
|
| Brand Name |
Enhertu
|
| Dosage Strength |
100 mg
|
| Dosage Form |
Powder for Concentrate for Solution for Infusion (IV)
|
| Classification |
Prescription (Rx) Drug
|
| Pharmacologic Category |
Human Epidermal Growth Factor Receptor 2 (HER2)
Inhibitor
|
| Packaging |
Type I amber glass vial and sealed with a fluoro-resin laminated butyl rubber stopper, and a polypropylene/ aluminum yellow flip-off crimp cap (Box of 1 vial)
|
| Manufacturer |
Baxter Oncology GmbH
|
| Country of Origin |
Germany
|
| Trader |
|
| Importer |
AstraZeneca Pharmaceuticals (Phils.), Inc.
|
| Distributor |
|
| Application Type |
Monitored Release
|
| Issuance Date |
15 January 2024
|
| Expiry Date |
15 January 2029
|